121 related articles for article (PubMed ID: 13106198)
1. Clinical assessment of tetra-sodium 2-methyl-1: 4-naphthohydroquinone diphosphate as a radiosensitiser in the radiotherapy of malignant tumours.
MITCHELL JS
Br J Cancer; 1953 Sep; 7(3):313-28. PubMed ID: 13106198
[No Abstract] [Full Text] [Related]
2. The effects of tetra-sodium 2-methyl 1:4-naphthohydroquinone diphosphate on early chick and amphibian embryos.
BELLAIRS R
Br J Cancer; 1954 Dec; 8(4):685-92. PubMed ID: 14351610
[No Abstract] [Full Text] [Related]
3. Historical changes produced by large doses of tetra-sodium 2-methyl-1:4-naphthohydroquinone diphosphate in some human'tumours.
MITCHELL JS
Experientia; 1949 Jul; 5(7):293-5. PubMed ID: 18133511
[No Abstract] [Full Text] [Related]
4. The effect of tetra-sodium 2-methyl-1:4-naphthohydroquinione diphosphate (synkayvite) on a variety of malignant tumours in experimental animals.
GELLHORN A; GAGLIANO T
Br J Cancer; 1950 Mar; 4(1):103-7. PubMed ID: 15420331
[No Abstract] [Full Text] [Related]
5. Experiments on the mechanism of action of tetra-sodium 2-methyl-1 : 4. naphthohydroquinone diphosphate as a mitotic inhibitor and radiosensitiser, using the technique of tissue culture. Experimental methods and quantitative results.
MITCHELL JS; SIMON-REUSS I
Br J Cancer; 1952 Sep; 6(3):305-16. PubMed ID: 12987557
[No Abstract] [Full Text] [Related]
6. Tritiated tetra sodium 2-methyl-1:4-naphthaquinol diphosphate for treatment of spontaneous tumours in animals.
SILVER IA; CATER DB; MARRIAN DH; MARSHALL B
Acta radiol; 1962 Aug; 58():281-300. PubMed ID: 13992923
[No Abstract] [Full Text] [Related]
7. Tracer studies of potential radiosensitizing agents: tetrasodium 2-methyl-3-82Br-bromo-1: 4-napthohydroquinone diphosphate and tetrasodium 2: 3-dimethyl-5: 6-di 131 I-iodo-1: 4-benzohydroquinone diphosphate.
MARRIAN DH; MAXWELL DR
Br J Cancer; 1956 Dec; 10(4):739-47. PubMed ID: 13426388
[No Abstract] [Full Text] [Related]
8. Studies of potential radiosensitizing agents: an effect of tetrasodium 2-methyl-1:4-naphthohydroquinone diphosphate (synkavit) on the Ehrlich mouse ascites tumour.
MARRIAN DH
Br J Cancer; 1959 Sep; 13(3):461-8. PubMed ID: 13848612
[No Abstract] [Full Text] [Related]
9. Tracer studies of potential radiosensitizing agents: tetrasodium 2-14C-methyl-1:4-naphthohydroquinone diphosphate.
MARRIAN DH; MAXWELL DR
Br J Cancer; 1956 Sep; 10(3):575-82. PubMed ID: 13396111
[No Abstract] [Full Text] [Related]
10. THE PHOSPHORYLATION REACTION THAT ACCOMPANIES THE NONENZYMIC OXIDATION OF 2-METHYL-1,4-NAPHTHOHYDROQUINONE DIPHOSPHATE.
TOMASI GE; DALLAM D
J Biol Chem; 1964 May; 239():1604-13. PubMed ID: 14197010
[No Abstract] [Full Text] [Related]
11. Studies of potential radiosensitizing agents. The effect of 2-methyl-1:4-naphthohydroquinone diphosphate (synkavit) on the level of adenosine triphosphate in mouse ascites tumour.
CHIPPERFIELD B; MARRIAN DH
Br J Cancer; 1962 Sep; 16(3):460-5. PubMed ID: 14020881
[No Abstract] [Full Text] [Related]
12. Experiments on the mechanism of action of tetrasodium 2 - methyl - 1 : 4- naphthohydroquinone diphosphate as a mitotic inhibitor and radiosensitiser, using the technique of tissue culture: relation between cytological effects and chemical constitution.
MITCHELL JS; SIMON-REUSS I
Br J Cancer; 1952 Sep; 6(3):317-38. PubMed ID: 12987558
[No Abstract] [Full Text] [Related]
13. Laboratory and clinical studies of some quinol diphosphates and related compounds as chemical radiosensitizers and the development of a radioactive drug.
MARRIAN DH; MARSHALL B; MITCHELL JS
Chemotherapia (Basel); 1961; 3():225-310. PubMed ID: 14470193
[No Abstract] [Full Text] [Related]
14. NEW and nonofficial remedies: sodium menadiol diphosphate.
J Am Med Assoc; 1953 May; 152(1):46-7. PubMed ID: 13034529
[No Abstract] [Full Text] [Related]
15. The histochemical dephosphorylation of certain sugar phosphates, alpha-naphthohydroquinone diphosphate and two chalcone diphosphates.
BOURNE GH
Acta Anat (Basel); 1954; 22(4):289-300. PubMed ID: 14349523
[No Abstract] [Full Text] [Related]
16. [Effect of synkavit (2-methyl-1:4 naphthohydrochinondiphosphate) on the roentgen irradiated and non-irradiated Ehrlich mouse carcinoma].
DITTRICH W; SCHMERMUND HJ
Strahlentherapie; 1953; 90(1):88-92. PubMed ID: 13076987
[No Abstract] [Full Text] [Related]
17. [Determination of sulfuric esters of 2-methyl-1, 4-naphthohydroquinone (vitamin K3) and of 4-methyl-aesculitin (vitamin P) in pharmaceutical products].
Mariani A; Mariani-Vicari C; Corsi F
Ann Ist Super Sanita; 1969; 5(5):565-77. PubMed ID: 5398546
[No Abstract] [Full Text] [Related]
18. Inhibition of Polymorphic Property of Naphthoquinonepigment Derived from Vitamin K.
Hara N; Tajima N; Kuroda R; Imai Y
J Oleo Sci; 2018; 67(10):1247-1252. PubMed ID: 30305557
[TBL] [Abstract][Full Text] [Related]
19. [Use of naphthidon as a radiosensitizer in radiotherapy of patients with malignant neoplasms].
Klimenko AA; Karlashenko NI
Med Radiol (Mosk); 1971 Dec; 16(12):41-3. PubMed ID: 5143205
[No Abstract] [Full Text] [Related]
20. [Stimulating effect of vicasol on the tumor process].
Sopotsinskaia EB
Vrach Delo; 1975 Feb; (2):127-8. PubMed ID: 1136388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
